Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...
The immediate consequences of the disappointing result are a big reduction in workforce at South San Francisco-based Alector, ...
Alkermes has reached an agreement to buy Avadel Pharma in a deal valued at up to $2.1 billion, claiming rights to an ...
Onsite at ESMO 2025, pharmaphorum spoke with Adrian Jubb, head of oncology and neurology clinical development at Corcept, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback